
RAPSN-Related Disorders: Muscle Weakness and Fatigue
When the RAPSN gene is altered, nerve signals reach muscle poorly, causing weakness and fatigue. EMG, nerve conduction studies and DNA testing point to the diagnosis.

MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.

When the RAPSN gene is altered, nerve signals reach muscle poorly, causing weakness and fatigue. EMG, nerve conduction studies and DNA testing point to the diagnosis.

Mutations in the RBBP8 gene underlie Seckel, Jawad and Cohen-Gibson syndromes, rare conditions involving growth delay and intellectual disability.

Low blood magnesium, high urinary calcium and kidney calcium deposits mark this disorder; blood, urine and imaging tests precede CLDN16 or CLDN19 analysis.

A child is affected only when both parents pass on a mutated copy of CLDN16, CLDN19, FXYD2 or EGF, so carrier testing informs family planning and prenatal screening.

One copy of the mutated gene from a single parent is enough to cause this form. Symptoms begin in childhood, and ERG and OCT support the eye examination.

About 1 in 4,000 people worldwide have retinitis pigmentosa, linked to mutations in over 60 genes. Testing shows whether it is dominant, recessive or X-linked.

When both parents pass on a mutated copy, a child develops recessive RP. A fundus exam shows bone spicule pigment, and carrier testing clarifies family risk.

A faulty ryanodine receptor brings muscle weakness, low tone and susceptibility to malignant hyperthermia. Subtypes, carrier status and anesthesia planning are covered.